Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?
Abstract Pancreatic cancer, especially in case of locally advanced stage has a poor prognosis. Radiotherapy in general can lead to tumor volume reduction, but further improvements, such as ion beam therapy have to be promoted in order to enable dose escalation, which in turn results in better local...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13014-017-0945-2 |
id |
doaj-70dcbf4dce7c45fb8d8f09c4346d352e |
---|---|
record_format |
Article |
spelling |
doaj-70dcbf4dce7c45fb8d8f09c4346d352e2020-11-25T00:04:50ZengBMCRadiation Oncology1748-717X2017-12-011211810.1186/s13014-017-0945-2Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?Constantin Dreher0Daniel Habermehl1Oliver Jäkel2Stephanie E. Combs3Department of Radiation Oncology, University Hospital Rechts der Isar, Technical University Munich (TUM)Department of Radiation Oncology, University Hospital Rechts der Isar, Technical University Munich (TUM)Department of Medical Physics in Radiation Oncology, German Cancer Research CenterDepartment of Radiation Oncology, University Hospital Rechts der Isar, Technical University Munich (TUM)Abstract Pancreatic cancer, especially in case of locally advanced stage has a poor prognosis. Radiotherapy in general can lead to tumor volume reduction, but further improvements, such as ion beam therapy have to be promoted in order to enable dose escalation, which in turn results in better local control rates and downsizing of the tumor itself. Ion beam therapy with its highly promising physical properties is also accompanied by distinct inter- and intrafractional challenges in case of robustness. First clinical results are promising, but further research in motion mitigation and biological treatment planning is necessary, in order to determine the best clinical rationales and conditions of ion beam therapy of pancreatic cancer. This review summarizes the current knowledge and studies on ion beam therapy of pancreatic cancer.http://link.springer.com/article/10.1186/s13014-017-0945-2Pancreatic cancerRBEIon beam therapyProtonsCarbon ionsParticle radiotherapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Constantin Dreher Daniel Habermehl Oliver Jäkel Stephanie E. Combs |
spellingShingle |
Constantin Dreher Daniel Habermehl Oliver Jäkel Stephanie E. Combs Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both? Radiation Oncology Pancreatic cancer RBE Ion beam therapy Protons Carbon ions Particle radiotherapy |
author_facet |
Constantin Dreher Daniel Habermehl Oliver Jäkel Stephanie E. Combs |
author_sort |
Constantin Dreher |
title |
Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both? |
title_short |
Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both? |
title_full |
Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both? |
title_fullStr |
Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both? |
title_full_unstemmed |
Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both? |
title_sort |
effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher rbe or both? |
publisher |
BMC |
series |
Radiation Oncology |
issn |
1748-717X |
publishDate |
2017-12-01 |
description |
Abstract Pancreatic cancer, especially in case of locally advanced stage has a poor prognosis. Radiotherapy in general can lead to tumor volume reduction, but further improvements, such as ion beam therapy have to be promoted in order to enable dose escalation, which in turn results in better local control rates and downsizing of the tumor itself. Ion beam therapy with its highly promising physical properties is also accompanied by distinct inter- and intrafractional challenges in case of robustness. First clinical results are promising, but further research in motion mitigation and biological treatment planning is necessary, in order to determine the best clinical rationales and conditions of ion beam therapy of pancreatic cancer. This review summarizes the current knowledge and studies on ion beam therapy of pancreatic cancer. |
topic |
Pancreatic cancer RBE Ion beam therapy Protons Carbon ions Particle radiotherapy |
url |
http://link.springer.com/article/10.1186/s13014-017-0945-2 |
work_keys_str_mv |
AT constantindreher effectiveradiotherapeutictreatmentintensificationinpatientswithpancreaticcancerhigherdosesalonehigherrbeorboth AT danielhabermehl effectiveradiotherapeutictreatmentintensificationinpatientswithpancreaticcancerhigherdosesalonehigherrbeorboth AT oliverjakel effectiveradiotherapeutictreatmentintensificationinpatientswithpancreaticcancerhigherdosesalonehigherrbeorboth AT stephanieecombs effectiveradiotherapeutictreatmentintensificationinpatientswithpancreaticcancerhigherdosesalonehigherrbeorboth |
_version_ |
1725427805051682816 |